欧洲黑色素瘤的预防与筛查:Euromelanoma运动20年
Euromelanoma是由皮肤科医生主导的欧洲组织,通过年度筛查活动、公众教育和标准化数据收集推动皮肤癌预防与早期诊断。自1999年创建以来,已在超过30个国家建立皮肤科医生网络,筛查并收集约420000名受试者的皮肤癌数据。本文回顾其历史、前十年成效及20年演变,并介绍未来针对特定人群的项目与当前挑战。
要点
- Euromelanoma通过年度筛查活动和网站资源提升公众对皮肤癌预防、早期诊断和治疗的意识。
- 该组织为科学界提供跨国合作平台,协调收集所有类型皮肤癌的流行病学、人口学、临床特征和危险因素的标准化数据。
- 自1999年创建以来,已在超过30个国家建立皮肤科医生网络,筛查并收集约420000名受试者的皮肤癌数据。
核心结论
- Euromelanoma在确保皮肤癌预防、治疗和诊断的重要性始终处于欧洲及国家医疗政策前沿方面发挥关键作用。
研究设计与样本
- 本文为综述,概述Euromelanoma的历史、前十年行动的益处及过去20年的演变 approach。
主要发现
- Euromelanoma现已拥有在超过30个国家工作的皮肤科医生网络,并已筛查和收集约420000名受试者的皮肤癌数据。
局限性
- 当前挑战包括需要改进非黑色素瘤皮肤癌病例的报告,以及提高对黑色素瘤亚型尤其是较难诊断的结节性黑色素瘤的认识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Euromelanoma is a Europe-wide, dermatologist-led organization that campaigns to have a public, scientific, and political impact on raising awareness of the prevention, early diagnosis, and treatment of skin cancer. The organization raises public awareness of skin cancer by providing practical support to participating countries for the roll out of yearly screening campaigns, and then builds on these campaigns by providing resources via its website to educate the general public on key skin cancer prevention measures, risk factors, and the importance of recognizing abnormal lesions through self-examination. Euromelanoma also provides a valuable platform for the scientific community, facilitating collaborations between countries and coordinating the collection of standardized data on the epidemiology, demographic and clinical characteristics, and risk factors for all forms of skin cancer. As our scientific understanding of skin cancer advances, Euromelanoma plays a key role in ensuring that the importance of skin cancer prevention, treatment, and diagnosis remains at the forefront of European and national healthcare policies. Since its creation in 1999, Euromelanoma has continued to evolve, adapt, and expand its approach to achieve these public, scientific, and political goals: the organization now has networks of dermatologists working in over 30 countries and has screened and gathered skin cancer data from around 420 000 subjects. This review highlights these achievements by providing an outline of the history of Euromelanoma and the benefits of the first decade of action and by describing the evolving approach over the past 20 years. Future Euromelanoma projects, which aim to evaluate skin cancer risk in specific populations (outdoor workers, organ transplant recipients, etc.) are also introduced, and current challenges for the Euromelanoma campaign are discussed, including the need to improve reporting of non-melanoma skin cancer cases and to raise awareness of melanoma subtypes, particularly the more difficult to diagnose nodular melanoma form.
引用
- Del Marmol V. Prevention and screening of melanoma in Europe: 20 years of the Euromelanoma campaign. J Eur Acad Dermatol Venereol. 2022. PMID: 35738812. doi:10.1111/jdv.18195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。